Skip to main content
RHYTHM PHARMACEUTICALS, INC. logo

RHYTHM PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · RYTM ISIN · US76243J1051 LEI · 529900JPNWXQ8DPLA551 US Manufacturing
Open in API
Filings indexed 775 across all filing types
Latest filing 2016-05-03 Regulatory Filings
Country US United States of America
Listing US RYTM

About RHYTHM PHARMACEUTICALS, INC.

https://rhythmtx.com/

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on developing and commercializing precision medicines for rare genetic diseases of obesity. The company's work centers on the melanocortin-4 receptor (MC4R) pathway, a key biological system that regulates hunger and energy expenditure. Its lead product, IMCIVREE® (setmelanotide), is an MC4R agonist approved for treating severe obesity and hyperphagia (insatiable hunger) in patients with specific rare conditions, such as Bardet-Biedl syndrome. Rhythm is dedicated to advancing a portfolio of therapies that address the root cause of rare neuroendocrine diseases to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2016
Regulatory Filings
2016-05-03 English
Regulatory Filings 2016
Regulatory Filings Classification · 100% confidence The document is a letter from the law firm Morgan, Lewis & Bockius LLP to the SEC Division of Corporation Finance regarding Rhythm Pharmaceuticals, Inc.'s Amendment No. 2 to a Draft Registration Statement on Form S-1. It references prior comments from the SEC staff and the company's responses, including updates to disclosures and compensation information. The document is a regulatory correspondence related to a registration statement filing, not the registration statement itself or a financial report. It is a response letter addressing SEC comments, which fits the category of Regulatory Filings (RNS) as it does not contain financial statements or substantive financial data but is a compliance and regulatory communication.
2016-04-06 English
Capital/Financing Update 2016
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a preliminary prospectus for Rhythm Pharmaceuticals, Inc. related to an initial public offering (IPO) of common stock. The text includes details about the offering, underwriting, risk factors, management discussion, and financial statements index. This type of filing is a registration statement for securities offering, which falls under the category of Capital/Financing Update (CAP) as it relates to fundraising and capital structure changes. It is not an annual report, earnings release, or other report types. The document length is substantial (15,000 characters), and it contains the full prospectus text, not just an announcement or link to a report, confirming it is the actual registration statement document.
2016-04-06 English
Regulatory Filings 2015
Regulatory Filings
2015-12-23 English
Regulatory Filings 2015
Regulatory Filings
2015-12-10 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a detailed letter from a law firm to the U.S. Securities and Exchange Commission responding to comments on a Draft Registration Statement on Form S-1 for Rhythm Pharmaceuticals, Inc. It discusses amendments to the Registration Statement, updates to disclosures, clinical trial information, risk factors, and financial condition. The Form S-1 is a registration statement used for initial public offerings (IPOs) and related securities offerings. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an earnings release or a call transcript. It is a regulatory filing responding to SEC comments on a registration statement, which fits the category of Regulatory Filings (RNS). The document is substantive and lengthy (15,000 characters), but it is not the report itself; it is a letter with amendments and responses to SEC staff comments. Therefore, the appropriate classification is Regulatory Filings (RNS).
2015-12-09 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.